Background Eclampsia is still prevalent in India with high maternal and perinatal mortality. In India, there is no community-based survey of eclampsia. Sporadic reports of study on eclampsia are being published in medical journals.Objectives The objective of this study was to find out the incidence of eclampsia and maternal and perinatal mortality in India. Methods Data on incidence, maternal mortality and perinatal mortality of eclampsia were collected from articles published in journals and from book of Abstract published during AICOG conferences from 1980 onwards, along with our own data from 1976 to 2014. Data were analyzed yearwise. Results Reports published from 1976 to 2015 (JanuaryFebruary) reveal that incidence of eclampsia in India ranges from 0.179 to 5 %, the average being 1.5 %. In the period between 1980 and 1989, the average incidence was 0.92 % and the corresponding figure between 2002 and 2010 was 2.15 %, indicating that there is no reduction in Dr. P. N. Nobis Retired as Professor and Head of the Department of Obstetrics and Gynecology from Silchar MedicalCollege is now working at International Hospital at Dispur, Guwahati, as Senior Consultant. He has about ten publications in National Journals including six in this journal. He has authored three textbooks of Obstetric and Gynaecology of which one is in vernacular. He has special interest in hypertensive disorders of pregnancy and pediatric gynecology.The Journal of Obstetrics and Gynecology of India (September-October 2016) 66(S1):S172-S176 DOI 10.1007/s13224-015-0807-5123 incidence of eclampsia in India over the decades. Maternal mortality in 1982 was 14.12 %, and in 2010 it was 2.2-9 %. Maternal mortality has shown a receding tendency, while perinatal mortality is remaining still high as in 1984 it was 45 % and the corresponding figure in 2010 was 24.5-48 %. Conclusion Incidence of eclampsia in India is about 1.5 %. Detail analysis of data from 1980 to 2015 (JanuaryFebruary) shows that there is no reduction in incidence of eclampsia and perinatal mortality rate over the last few decades. Maternal mortality has shown a slight receding trend.
Objective: To study the prevalence, aetiology and prognosis of obstetric acute renal failure (ARF). Methodology: This retrospective study was carried out in International Hospital, Guwahati from January 2002 to December 2009. Forty one (41) cases treated during this period was referred from various centres. Cases were analysed to find out the prevalence, causative factors and prognosis in relation to aetiology, time of referral, and severity of renal failure. Results: Out of 2022 admitted obstetrics patients 41 patients had ARF and were referred for PPH, sepsis, shock or oligo-anuria. Majority (65.85%) patients were in the age group of 20 to 30years. Maximum cases 63.41% developed ARF during post partum period. Incidence was more following LSCS (46.34%) compared to 17.07% following vaginal birth. Aetiology was found to be multifactorial and 76.47% patients recovered with haemodialysis. Mortality rate was (5/41) 12.20%. Prognosis was found to be better in cases of early referral and worse in presence of sepsis. Conclusion: Obstetric ARF a problem of multifactorial aetiology, remains as an important cause of maternal death.
Peripartum cardiomyopathy is a rare idiopathic cardiac disease occurring in pregnancy and puerperium. Studies have shown that women with preeclampsia have a higher risk of developing peripartum cardiomyopathy. In this report we present a case of a 3 rd trimester pregnancy with severe preeclampsia with acute kidney injury who was diagnosed with peripartum cardiomyopathy. Supportive management was done with a multidisciplinary approach. Caesarean section was done, an IUGR but healthy baby was delivered and the patient recovered gradually.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.